3.
F344 | HLA-B27 + IgG 18ws | HLA-B27 + Ab 18ws | HLA-B27 + IgG 27ws | HLA-B27 + Ab 27ws | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fas | IEC | 9.14 ± 5.06 | 18.01 ± 0.54* | 5.30 ± 2.43§ | 15.69 ± 5.72* | 5.64 ± 1.28§ | ||||||||||||||||||||
LP | 33.87 ± 7.59 | 19.85 ± 2.25* | 26.07 ± 3.05§ | 21.33 ± 2.3* | 27.57 ± 6.9 | |||||||||||||||||||||
Fas-L | IEC | 12.21 ± 3.49 | 5.59 ± 3.46* | 3.77 ± 3.64* | 3.94 ± 2.74* | 7.31 ± 4.93* | ||||||||||||||||||||
LP | 5.23 ± 1.36 | 13.48 ± 1.86** | 14.2 ± 2.8 | 11.39 ± 2.14** | 11.87 ± 2.23 |
Data are shown as means ± S.D. IEC = intestinal epithelial cells, LP = lamina propria. *P < 0.05, **P < 0.01 versus F344; §P < 0.05 versus IgG-treated HLA-B27 transgenic rats.